Latest MS research news

Latest MS research news | 10 December 2012

Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-Beta

In this study, researchers looked at the relationship between nonresponders (NR) and interleukin-17 (IL-17A) serum titres, as well as binding antibodies (BAbs) to interferon-β (IFN-β) therapy. IL-17A is a proinflammatory cytokine which is involved in the pathogenesis of MS.

From MSIF

Latest MS research news | 10 December 2012

Axial 3D gradient-echo imaging for improved MS lesion detection in the cervical spinal cord at 3T

This study looked at axial 3D gradient-recalled echo sequences performed both with and without a magnetization transfer prepulse and compared them to T2-weighted fast-spin-echo images, for the detection of MS lesions in the cervical cord on 3T.

From MSIF

Latest MS research news | 10 December 2012

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study

This interesting, long-term, randomised cohort study, looked at the cause of death 21 years after the start of the pivotal interferon (IFN) β-1b.

From MSIF

Latest MS research news | 04 December 2012

Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS

This study group from New York looked at diffuse grey matter (GM) and white matter (WM) metabolic abnormalities in 18 people with early RRMS, with a mean EDSS of 1.3 on immunomodulatory medication.

From MSIF

Latest MS research news | 04 December 2012

Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?

This study examined the net effects of corticosteroids (CS) on the virus-specific T-cell responses, especially JC virus, to determine the optimal timing of corticosteroid administration in patients with MS with natalizumab-caused PML-IRIS.

From MSIF

Latest MS research news | 04 December 2012

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

This study looked at biomarkers of inflammation, axonal damage and demyelination in the CSF and to see if these biomarkers are associated with progressive MS.

From MSIF

Latest MS research news | 27 November 2012

Heat sensitive persons with multiple sclerosis are more tolerant to resistance exercise than to endurance exercise

This study looked at 16 heat sensitive people with MS, who were randomly allocated a session of resistance exercise (RE) and endurance exercise (EE) or EE and RE respectively.

From MSIF

Latest MS research news | 27 November 2012

Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS

The researchers recruited 18 patients with RRMS and performed T1 weighted, T2-weighted MRI and 3D proton magnetic resonance spectroscopic imaging (H-MRSI) every 6 months for 3 years.

From MSIF

Latest MS research news | 27 November 2012

Long-term outcome of paediatric-onset MS: a population-based study

This population based study from the UK looked at clinical features and accumulation of disability in paediatric-onset MS (<18 years) and compared it to a cohort of patients with adult-onset MS...

From MSIF

Latest MS research news | 20 November 2012

Multiple sclerosis: Oral BG12 for treatment of relapsing-remitting MS

This review article looks at two large phase III trials which looked at the clinical efficacy and safety profile of oral dimethyl fumarate (BG12) in patients with relapsing-remitting MS.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial